As described by Liu et al., breast cancer associated AIM2 up-regulation can decrease the expression of anti-apoptotic B-cell lymphoma-extra large (Bcl-xL) and increase the expression of pro-apoptotic Bcl-2-associated protein x (Bax) determining the inhibition of breast cancer cell growth64. This evidence concerns the gene BCL2L1 and breast cancer.